Jazz Pharmaceuticals (NASDAQ:JAZZ) initiated with Buy rating and $149 (51% upside) price target at Jefferies.
Walgreens Boots Alliance (NASDAQ:WBA) upgraded to Neutral with a $44 (8% upside) price target at UBS. Shares up 2% premarket.
Acceleron Pharma (NASDAQ:XLRN) downgraded to Sell with a $73 (10% downside risk) price target at Goldman Sachs.
Viela Bio (NASDAQ:VIE) downgraded to Sell with a $36 (17% upside) price target at Goldman.
https://seekingalpha.com/news/3558501-jefferies-sees-51-upside-in-jazz-pharma-in-premarket-analyst-action
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.